Efficacy and Safety of Bioresorbable Vascular Scaffolds Versus Contemporary Drug-Eluting Stents in Coronary Artery Disease: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis
Reviews in Cardiovascular Medicine · 20.10.2026 · 27 (10)
DOI: 10.31083/rcm51636 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 20.10.2026. Verfasst von Yue Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Center of Valve Heart Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases - National Science and Technology Major Project, Noncommunicable Chronic Diseases - National Science and Technology Major Project 5.
Abstract (Originalsprache)
Background
Bioresorbable vascular scaffolds (BVS) were developed to address some limitations associated with permanent metallic drug-eluting stents (DES), but the comparative safety and efficacy of these scaffolds remain uncertain.
Methods
We conducted a systematic review and meta-analysis of randomized and observational studies comparing BVS with contemporary DES in patients with coronary artery disease. The primary outcome was the composite clinical endpoint at 1-year. Secondary outcomes included mortality, myocardial infarction (MI), revascularization, thrombosis, and angiographic measures. Outcomes at 2, 3, and 5 years were analyzed separately. Trial sequential analysis (TSA) was used to assess the robustness of the evidence for the primary outcome.
Results
A total of 51 studies (69 reports) were included. At 1 year, BVS was associated with a higher risk of the composite clinical endpoint than DES (risk ratio (RR) 1.11, 95% confidence interval (CI 1.00–1.22)), mainly driven by increased risks of MI, target lesion revascularization, and thrombosis. In contrast, all-cause and cardiac mortality did not differ significantly between groups. TSA showed that although the cumulative Z-curve reached the required information size, the Z-score did not cross the trial sequential monitoring boundary, indicating that the evidence for the primary endpoint remained inconclusive. During mid- and long-term follow-up, BVS remained associated with higher risks of ischemic events and repeat revascularization, without a survival benefit. Angiographic analyses showed greater late lumen loss, smaller minimal lumen diameter, and greater diameter stenosis with BVS.
Conclusions
Compared with contemporary DES, BVS appears to confer a higher ischemic risk without a long-term mortality benefit. Contemporary DES remains the preferred revascularization strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interventional Center of Valve Heart Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China.
ORCID-Profile: Yue Yu, Ke Shang, Yuemiao Jiao, Sanshuai Chang, Yang Li, Guangyuan Song, Chengqian Yin
Förderung
- Noncommunicable Chronic Diseases - National Science and Technology Major Project
- Noncommunicable Chronic Diseases - National Science and Technology Major Project 5
Zitieren
APA
Yu, Y., Shang, K., Jiao, Y., Chang, S., Li, Y., Song, G., & Yin, C. (2026). Efficacy and Safety of Bioresorbable Vascular Scaffolds Versus Contemporary Drug-Eluting Stents in Coronary Artery Disease: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. Reviews in Cardiovascular Medicine, 27(10). https://doi.org/10.31083/rcm51636
Vancouver
Yu Y, Shang K, Jiao Y, Chang S, Li Y, Song G, et al. Efficacy and Safety of Bioresorbable Vascular Scaffolds Versus Contemporary Drug-Eluting Stents in Coronary Artery Disease: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. Reviews in Cardiovascular Medicine. 2026;27(10). doi:10.31083/rcm51636
BibTeX
@article{Yu2026,
author = {Yu, Yue and Shang, Ke and Jiao, Yuemiao and Chang, Sanshuai and Li, Yang and Song, Guangyuan and Yin, Chengqian},
title = {Efficacy and Safety of Bioresorbable Vascular Scaffolds Versus Contemporary Drug-Eluting Stents in Coronary Artery Disease: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
volume = {27},
number = {10},
doi = {10.31083/rcm51636}
}
EUVIMED